Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis

Jürgen Barth1, Martina Schumacher, Christoph Herrmann-Lingen

  • 1Department of Rehabilitation Psychology, Institute of Psychology, University of Freiburg, Germany. mail@juergen-barth.de

Psychosomatic Medicine
|November 27, 2004
PubMed

Insights

Depression significantly increases mortality risk in coronary heart disease (CHD) patients. Both depressive symptoms and clinical depression are linked to higher death rates, emphasizing depression as a key risk factor in CHD care.

Area of Science:

  • Cardiology
  • Psychiatry
  • Epidemiology

Background:

  • Prospective studies link depression to increased coronary heart disease (CHD) risk in healthy individuals.
  • The relative risk for any CHD event in depressed individuals is 1.64.
  • The impact of depression on CHD patients' mortality has not been meta-analyzed.

Purpose of the Study:

  • To quantify the impact of depressive symptoms or disorders on cardiac and all-cause mortality in CHD patients.
  • To analyze the strength and time dependency of this relationship.
  • To compare the predictive value of depressive symptoms versus clinical depression diagnosis.

Main Methods:

  • A meta-analysis of prospective cohort studies published in English and German from 1980 to 2003.
  • Searched databases included Medline, PsycInfo, and PSYNDEX.
  • A random model was used to estimate combined effects (odds ratios or adjusted hazard ratios).

Main Results:

  • Depressive symptoms significantly increase mortality risk in CHD patients, with a two-fold higher risk within 2 years (OR, 2.24).
  • This increased risk persists long-term (OR, 1.78) and after adjusting for other risk factors (HR [adj], 1.76).
  • Clinical depression also elevates mortality risk, especially after 2 years (OR, 2.61).

Conclusions:

  • Both depressive symptoms and clinical depression are unfavorable prognostic factors for mortality in CHD patients.
  • Depression should be considered a relevant risk factor in managing CHD.
  • Further research is needed to clarify the predictive precision of self-report versus clinical interview methods.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...